Last update: Sept. 19, 2016

Хинфамид

Very Low Risk for breastfeeding


Safe. Compatible.
Minimal risk for breastfeeding and infant.

Antiamoebic agent with intraluminal action.

At latest update no published data were found regarding breastfeeding.

Its low intestinal absorption makes it highly unlikely the passage of significant amounts into breast milk as well as it would not be absorbed by the infant intestine.

Alternatives

We do not have alternatives for Хинфамид since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Хинфамид is Quinfamide in Cyrillic.

Is written in other languages:

Group

Хинфамид belongs to this group or family:

Tradenames

Main tradenames from several countries containing Хинфамид in its composition:

List of 11 tradenames
  • Amefin™
  • Amenox™
  • Amoebriz™. Contains other elements than Хинфамид in its composition
  • Bensolmin Complex ™. Contains other elements than Хинфамид in its composition
  • Bisidim™
  • Farmiver™. Contains other elements than Хинфамид in its composition
  • Loxcell NF ™. Contains other elements than Хинфамид in its composition
  • Luminovag™
  • Oxal™. Contains other elements than Хинфамид in its composition
  • Serphamida™
  • Vermox-Plus™. Contains other elements than Хинфамид in its composition

Pharmacokinetics

Variable Value Unit
Oral Bioavail. Baja - Poor %
Molecular weight 354 daltons

References

  1. ROMERO-CABELLO, RAÚL et al. Evaluation of the efficacy and security of quinfamide administered in a single dose of 300 mg in adult patients with intestinal amebiasis. Parasitol. latinoam. 2005, vol.60, n.1-2, pp.57-60. 2005 Full text (link to original source) Full text (in our servers)

Total visits

903

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM